Advertisement
外匯新聞
AbbVie Reports Top-line Results From Phase 3 SEQUENCE Clinical Trial Of Risankizumab
Biopharmaceutical company AbbVie, Inc. (ABBV) announced Tuesday top-line results from the Phase 3 SEQUENCE clinical trial evaluating risankizumab (SKYRIZI, 600 mg intravenous [IV] induction at week 0, 4 and 8 and 360 mg subcutaneous injection [SC] starting at week 12 and every 8 weeks thereafter) versus ustekinumab (STELARA, IV dose at week 0 and 90 mg SC every 8 weeks thereafter) through week 48 in patients with moderately to severely active Crohn's disease who have failed one or more anti-TNFs.
RTTNews |
639天前
Canadian Shares Seen Opening On Mixed Note
Bay Street looks headed for a mixed start on Tuesday, tracking European stocks and commodities markets.
RTTNews
|
639天前
EBay Launches New Luxury Consignment Service
eBay, Inc. (EBAY) announced Tuesday the introduction of a new consignment service, giving users direct access to expert sellers who will list and sell their luxury items on their behalf.
RTTNews
|
639天前
Neurocrine Biosciences Reports Positive Top-line Data From Phase 3 Study Of Crinecerfont
Neurocrine Biosciences, Inc. (NBIX) announced Tuesday positive top-line data from the Phase 3 CAHtalyst Adult Study evaluating the efficacy, safety, and tolerability of crinecerfont in adults with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD).
RTTNews
|
639天前
Pound Falls After Tepid Labor Market Data
The pound slipped against its major counterparts in the European session on Tuesday, as an increase in the nation's jobless rate pointed to softening in the labor market.
RTTNews
|
639天前
Lyra Therapeutics Reports Positive Topline Results From BEACON Phase 2 Study Of LYR-220
Biotechnology company Lyra Therapeutics, Inc. (LYRA) announced Tuesday positive topline results from the BEACON Phase 2 clinical study of LYR-220 in adult patients with CRS, with and without polyps, who have had prior ethmoid sinus surgery.
RTTNews
|
639天前
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman
Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.
RTTNews
|
639天前
more news
German ZEW Economic Confidence Improves Moderately
Germany's economic sentiment unexpectedly improved in September as interest rates are estimated to have peaked in the euro area and the U.S., but financial market experts' assessment of the current situation turned more pessimistic, survey data from the ZEW-Leibniz Centre for European Economic Research showed Tuesday. The ZEW Indicator of Economic Sentiment unexpectedly rose to a three-month high
RTTNews
|
639天前
Affimed Says FDA Grants Fast Track Designation For AFM13 With AlloNK To Treat R/r Hodgkin Lymphoma
Immuno-oncology company Affimed N.V. (AFMD) announced that the FDA has granted fast track designation to the combination of its innate cell engager (ICE) AFM13 with AlloNK for the potential treatment of relapsed/refractory (r/r) Hodgkin lymphoma (HL).
RTTNews
|
639天前
Sensex, Nifty End On Flat Note; Small And Midcap Stocks Slump
Indian shares ended a choppy session on a flat note Tuesday, even as small and mid-cap stocks witnessed significant selling pressure after the recent rally.
RTTNews
|
639天前
European Shares Mixed In Cautious Trade
European stocks traded mixed on Tuesday as investors looked ahead to the release of U.S. inflation data along with the ECB policy meeting this week for directional cues.
RTTNews
|
639天前
FTSE 100 Edges Higher On Pound Weakness
U.K. stocks rose on Tuesday as the British pound weakened after the release of mixed labor market data.
RTTNews
|
639天前
CAC 40 Subdued As Investors Look To ECB
French stocks traded slightly lower on Tuesday as investors awaited a slew of U.S. data along with the ECB policy meeting this week for directional cues.
RTTNews
|
639天前
Stay up to date!
Add 新聞 to your browser
Add To Chrome
